The Latest Cardiac and Vascular News
Initial INSIGHT Registry data demonstrated RED® reperfusion catheters were highly effective in removing all clot types with an impressive 68.9% mTICI > 2b-3 overall first pass effect rate COMPLETE study sub-analyses of tandem lesions and late window showed aspiration thrombectomy with Penumbra System® restored blood flow and resulted in improved 90-day […]
ALAMEDA, Calif., Aug. 4, 2022 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second quarter ended June 30, 2022. Revenue of $208.3 million in the second quarter of 2022, an increase of 13.1%, or 15.3% in constant currency1, compared to the second quarter of […]
News from Penumbra Inc. June 23, 2022 ALAMEDA, Calif.–Penumbra Inc. (NYSE: PEN) shared that its latest RED Reperfusion Catheters received approval from Health Canada, expanding on the company’s extensive portfolio of innovative stroke products in Canada. The RED Catheters are designed with optimized trackability to help navigate the complex distal vessel anatomy […]
ALAMEDA, Calif., May 3, 2022 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2022. Revenue of $203.9 million in the first quarter of 2022, an increase of 20.5%, or 21.8% in constant currency1, compared to the first quarter of […]
Physicians in Europe now have access to Penumbra’s most advanced mechanical thrombectomy technology available, which has had a significant impact on patients in the U.S. Designed for single session blood clot removal in peripheral arterial and venous systems, including the treatment of pulmonary embolisms First and only computer-aided mechanical aspiration […]
ALAMEDA, Calif., Feb. 22, 2022 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2021. Financial Highlights: Revenue of $204.0 million for the fourth quarter of 2021, an increase of 22.2% compared to revenue of $166.9 million for the fourth quarter […]
CAT RX established high rates of blood clot removal, blood flow restoration and myocardial perfusion normalization No serious adverse events associated with the use of sustained power aspiration Results of the CHEETAH clinical study were presented at the 2021 Transcatheter Cardiovascular Therapeutics (TCT) conference ALAMEDA, Calif. – November 5, 2021 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced that the CHEETAH clinical study of its Indigo® System CATTM RX Catheter successfully met the primary endpoint and […]
Developed in partnership with Penumbra, Inc., Rapid Workflow for PE supports faster team activation to accelerate PE care and drive better patient outcomes SAN MATEO, Calif., June 24, 2021 /PRNewswire/ — RapidAI, leading the next evolution of clinical decision making and patient workflow, today announced the availability of Rapid Workflow for PE, a mobile […]
Now available in the U.S., RED™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood clots First catheter of new RED series expands the company’s extensive portfolio of innovative stroke products ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, […]
Latest System Designed for Single Session Arterial Thrombus Removal ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Indigo® System Lightning™ 7. Lightning 7 expands Penumbra’s offering of the Indigo Aspiration System with Intelligent Aspiration for mechanical thrombectomy and is […]
